Screening for microalbuminuria according to the ADA guidelines in patients with diabetes mellitus

by Mulondo, Jacqueline, M.S.N., NORTHERN KENTUCKY UNIVERSITY, 2007, 39 pages; 1447083


Diabetic nephropathy is one prevalent complication of diabetes leading to a high financial liability for the healthcare system. The manifestation of low but abnormal levels of urine albumin referred to as microalbuminuria is the initial confirmation of nephropathy. The American Diabetes Association recommends annual screening for microalbuminuria in type 1 diabetic patients starting five years after diagnosis. Annual screening for patients with type 2 diabetes mellitus should start at the time of diagnosis. The purpose of this study was to determine if healthcare providers were adhering to the ADA recommendations related to screening for microalbuminuria in patients with diabetes mellitus. Of the 150 charts reviewed, the percentage of charts reflecting a quantitative value of microalbuminuria documented in the charts of patients with type 2 diabetes mellitus once per calendar year was 44.7% (n=67). Efforts should be made to educate healthcare providers about standards of care, which include adhering to the recommended guidelines.

AdviserCarrie McCoy
Source TypeThesis
Publication Number1447083

About ProQuest Dissertations & Theses
With nearly 4 million records, the ProQuest Dissertations & Theses (PQDT) Global database is the most comprehensive collection of dissertations and theses in the world. It is the database of record for graduate research.

PQDT Global combines content from a range of the world's premier universities - from the Ivy League to the Russell Group. Of the nearly 4 million graduate works included in the database, ProQuest offers more than 2.5 million in full text formats. Of those, over 1.7 million are available in PDF format. More than 90,000 dissertations and theses are added to the database each year.

If you have questions, please feel free to visit the ProQuest Web site - - or contact ProQuest Support.